Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032

Overview

The Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market is expected to reach a 29.66 USD Million by 2032 and is projected to grow at a CAGR of 5.83% from 2025 to 2032.

Revenue, 2024 (USD Million)

20.55

Forecast, 2032 (USD Million)

29.66

CAGR, 2024 - 2032

5.83%

Report Coverage

Middle East & Africa

Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market 2018-2032 USD Million

Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 20.55 USD Million
Projected Market Size (2032): 29.66 USD Million
CAGR (2025-2032): 5.83%

Key Findings of Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market

The Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market was valued at 20.55 USD Million in 2024.
The Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market is likely to grow at a CAGR of 5.83% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Human iPSCs in Type Segment accounted for the largest share of the market with a revenue of 14.45 USD Million
The fastest growing segment Biotechnology & Pharmaceutical Companies in End User Segment grew Fastest with a CAGR of 8.16% during the forecast period from 2024 to 2032.

Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Scope

Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Segmentation & Scope

Application

Others
3D Bioprinting
Stem Cell Banking
Toxicology Screening
Regenerative Medicine
Cellular Therapy
Disease Modelling
Academic Research
Drug Discovery And Development

End User

Others
Diagnostic Laboratories
Research Laboratories
Biotechnology & Pharmaceutical Companies

Distribution Channel

Retail Sales
Direct Tender

Product

Instruments
Services
Consumables & Kits

Type

Mouse iPSCs
Human iPSCs

Cell Source

Blood Cells
Skin Cells

Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Data Coverage Insights

Study Period	2024-2032
Base Year	2022
Unit	Revenue in USD Million
Market Value in 2024	20.55 USD Million
Market Value in 2032	29.66 USD Million
CAGR (2025-2032)	5.83%
Historic Data	2016-2023
Market Segments Covered	Application,End User,Distribution Channel,Product,Type,Cell Source

Regional Insights:

Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 20.55 USD Million in 2024
- Key Country: South Africa, leading in terms of revenue with value of 7.55 USD Million in 2024.

Segments and Scope

Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Application
- Drug Discovery And Development is the largest segment in Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 4.77 USD Million in the year 2024.
- Academic Research is the Fastest growing segment in Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 6.19 % in forecast period 2025-2032.
Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By End User
- Biotechnology & Pharmaceutical Companies is the largest segment in Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 10.19 USD Million in the year 2024.
- Biotechnology & Pharmaceutical Companies is the Fastest growing segment in Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 8.16 % in forecast period 2025-2032.
Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 13.47 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 6.76 % in forecast period 2025-2032.
Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Product
- Consumables & Kits is the largest segment in Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 10.62 USD Million in the year 2024.
- Consumables & Kits is the Fastest growing segment in Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 6.89 % in forecast period 2025-2032.
Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Type
- Human iPSCs is the largest segment in Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 14.45 USD Million in the year 2024.
- Human iPSCs is the Fastest growing segment in Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 6.62 % in forecast period 2025-2032.
Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Cell Source
- Skin Cells is the largest segment in Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 13.29 USD Million in the year 2024.
- Skin Cells is the Fastest growing segment in Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 6.05 % in forecast period 2025-2032.

Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Company Share Analysis

Company Name
Merck KGaA
Lonza
Thermo Fisher Scientific Inc.
Evotec SE
FUJIFILM Corporation

Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Geographical Sales Distribution, 2018-2032 USD Million

Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market

Middle East & Africa Cold Sore Treatment Market

North America Cold Sore Treatment Market

Europe Cold Sore Treatment Market

Asia-Pacific Cold Sore Treatment Market

Argentina Cold Sore Treatment Market

Australia Cold Sore Treatment Market

Austria Cold Sore Treatment Market

Belgium Cold Sore Treatment Market

Brazil Cold Sore Treatment Market

Frequently Asked Questions

What are the primary segments covered in the Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market?

The Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market is segmented based on Segmentation Application,End User,Distribution Channel,Product,Type,Cell Source.

What is the current market size of the Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market?

Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market was valued at USD 20.55(Revenue in USD Million) in 2022.

What is the expected growth rate of the Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market?

Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market is projected to grow at a CAGR of 5.83% during the forecast period of 2024 to 2032.

Which is the dominating segment in the Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market?

The Human iPSCs segment is expected to dominate the Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market, holding a largest market share of 14.45 USD Million in 2024